Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
210032664 210008724 1.67 65 Curative (C) 2015-12-27 2016-04-27 UKALL14- Intens/CNS Proph N N 210016247 UKALL2014
210032665 210008729 1.76 86.2 Curative (C) 2017-01-16 2018-01-12 UKALL14- Ph 2 Induction Y N 210016258 UKALL2014
210032666 210008735 1.65 0 null 2017-02-02 2017-09-15 UKALL14- Intens/CNS Proph y N 210016266 UKALL2014
210032667 210008742 1.88 87 Curative (C) 2016-10-17 2016-10-26 UKALL14- Ph 1 Induction Y N 210016281 UKALL2014
210032668 210008748 1.78 52 Curative (C) 2014-09-04 2014-11-11 UKALL14- Ph 2 Induction 02 N 210016287 UKALL2014
210032669 210019533 1.62 73.6 Curative (C) 2014-08-07 2014-08-15 UKALL14- Ph 2 Induction N N 210016296 UKALL2014
210032670 210034881 1.71 85 Curative (C) 2013-09-01 2013-12-10 UKALL14- Ph 2 Induction N N 210016307 UKALL2014
210032671 210008754 null 95.799 Curative (C) 2012-08-16 2013-05-20 UKALL14- Maintenance N null 210016308 UKALL2014
210032672 210008760 1.61 60.9 Curative (C) 2017-07-14 2018-04-21 UKALL14- Ph 2 Induction N null 210016323 UKALL2014
210032673 210008764 1.87 null Curative (C) 2017-04-23 2017-08-04 UKALL14- Ph 2 Induction + Imatinib Y null 210016332 UKALL2014
210032674 210008771 1.73 138 Curative (C) 2014-05-10 2014-05-10 UKALL14- Intens/CNS Proph null N 210016336 UKALL2014
210032675 210008776 1.75 62.1 Curative (C) 2016-07-26 2016-07-26 UKALL14- Ph 2 Induction Y N 210016344 UKALL2014
210032676 210008780 1.68 97.8 Curative (C) 2014-10-14 2015-01-14 UKALL14- Cons Cycle 2 N N 210016347 UKALL2014
210032677 210008782 1.67 null Curative (C) 2017-08-05 2017-12-01 UKALL 14 TRIAL 1 N 210016352 UKALL2014
210032678 210008784 1.52 83 Curative (C) 2015-11-22 2016-08-20 UKALL14- Cons Cycle 1 Y N 210016365 UKALL2014
210032679 210008787 null 60.5 Curative (C) 2016-01-21 2016-10-26 UKALL14- Intens/CNS Proph Y null 210016374 UKALL2014
210032680 210008793 null 70.1 Curative (C) 2015-04-07 2015-04-07 UKALL14- Maintenance Y N 210016377 UKALL2014
210032681 210008802 1.56 85 Adjuvant (A) 2018-02-08 2018-03-19 UKALL14- Cons Cycle 1 Y N 210016410 UKALL2014
210032682 210026474 1.93 103 Curative (C) 2014-07-26 2015-02-28 UKALL 14 TRIAL N N 210016427 UKALL2014
210032683 210036018 null 115.3 Curative (C) null 2014-01-06 UKALL14- Maintenance N null 210016429 UKALL2014
210032684 210008806 1.6 84.9 Curative (C) 2018-03-20 2018-09-09 UKALL 14 TRIAL Y N 210016434 UKALL2014
210032685 210008810 1.69 70.1 Curative (C) null 2017-09-16 UKALL14- Cons Cycle 2 Y N 210016439 UKALL2014
210032686 210026475 1.72 86.8 Curative (C) 2016-10-11 2016-11-11 UKALL14- Intens/CNS Proph Y N 210016439 UKALL2014
210032687 210038129 1.74 70 Curative (C) 2015-12-30 2016-10-20 UKALL14- Cons Cycle 2 N N 210016457 UKALL2014
210032688 210008817 1.78 143.5 Curative (C) 2013-02-22 2015-04-29 UKALL 14 TRIAL N N 210016482 UKALL2014
210032689 210008821 null 75 Curative (C) 2017-03-09 2017-07-03 UKALL14- Ph 2 Induction + Imatinib N null 210016503 UKALL2014
210032690 210008826 1.9 106.499 Curative (C) 2017-02-05 2017-04-12 UKALL14- Intens/CNS Proph Y N 210016514 UKALL2014
210032691 210008831 1.64 61 Curative (C) 2014-08-02 2014-08-02 UKALL14- Maintenance Y N 210016535 UKALL2014
210032692 210008832 1.85 85.7 Curative (C) 2017-03-01 2017-09-22 UKALL14- Cons Cycle 1 N N 210016537 UKALL2014
210032693 210008835 1.76 67.1 Curative (C) 2016-10-03 2016-10-03 UKALL14- Cons Cycle 2 Y null 210016538 UKALL2014
210032694 210008836 1.75 62 Curative (C) 2017-09-09 2017-10-01 UKALL14- Cons Cycle 1 01 null 210016577 UKALL2014
210032695 210008837 null 68.7 Curative (C) 2013-11-29 2013-11-29 UKALL14- Cons Cycle 2 02 N 210016582 UKALL2014
210032696 210008838 1.65 45 Curative (C) 2015-09-30 2015-10-03 UKALL 14 TRIAL Y null 210016587 UKALL2014
210032697 210019588 1.93 84.9 Curative (C) 2018-01-02 2018-04-10 UKALL14- Intens/CNS Proph 2 N 210016593 UKALL2014
210032698 210008843 1.78 74.9 Curative (C) 2013-01-12 2013-09-21 UKALL14- Maintenance 01 N 210016611 UKALL2014
210032699 210008849 1.65 58.8 Curative (C) 2013-08-02 2013-12-01 UKALL14- Cons Cycle 1 N N 210016625 UKALL2014
210032700 210019595 1.67 69 Curative (C) 2014-04-29 2014-10-16 UKALL14- Cons Cycle 3 Y N 210016637 UKALL2014
210032701 210008854 1.82 69.1 Curative (C) 2017-07-06 2017-12-10 UKALL14- Cons Cycle 1 02 N 210016650 UKALL2014
210032702 210008862 1.88 87.5 Curative (C) 2018-09-03 2018-09-03 UKALL14- Cons Cycle 1 Y null 210016706 UKALL2014
210032703 210008864 1.74 93.4 Curative (C) 2016-05-15 2017-03-14 UKALL14- Cons Cycle 2 N N 210016712 UKALL2014
210032705 210019604 1.84 65 Curative (C) 2014-04-11 2014-09-18 UKALL14- Ph 1 Induction 1 N 210016751 UKALL2014
210032706 210008873 1.89 75 Curative (C) 2017-12-13 2018-12-17 UKALL14- Cons Cycle 3 N N 210016759 UKALL2014
210032707 210008876 1.8 89.7 Curative (C) 2017-02-21 2017-11-14 UKALL14- Cons Cycle 2 N N 210016766 UKALL2014
210032708 210026497 1.6 74 Curative (C) 2016-02-23 2016-10-11 UKALL 14 TRIAL N null 210016773 UKALL2014
210032709 210008881 1.64 82 Curative (C) 2014-08-24 2015-04-26 UKALL14- FMC (1 day) Conditioning 01 N 210016782 UKALL2014
210032710 210008885 1.75 63 Curative (C) 2014-07-21 2015-01-06 UKALL 14 TRIAL Y N 210016786 UKALL2014
210032711 210008887 null 80 Disease modification (D) null 2017-09-20 UKALL14- Maintenance Y N 210016787 UKALL2014
210032712 210008890 1.72 75.2 Curative (C) 2015-10-23 2015-10-27 UKALL14- Cons Cycle 3 null null 210016794 UKALL2014
210032713 210008892 1.72 106.5 Curative (C) 2015-03-25 2017-01-07 UKALL14- Ph 1 Induction 01 null 210016826 UKALL2014
210032714 210008895 1.72 70.1 Curative (C) 2014-11-21 2015-09-10 UKALL14- Cons Cycle 3 01 N 210016838 UKALL2014